Department of Nephrology, the Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao, 266003, China.
Central Laboratory, the Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao 266003, China.
Sci Rep. 2016 Sep 20;6:33652. doi: 10.1038/srep33652.
Primary hyperoxaluria type 1 (PH1) is a rare genetic disease characterized by excessive oxalate accumulation in plasma and urine, resulting in various phenotypes because of allelic and clinical heterogeneity. This study aimed to detect disease-associated genetic mutations in three PH1 patients in a Chinese family. All AGXT exons and 3 common polymorphisms which might synergistically interact with mutations, including P11L, I340 M and IVSI+74 bp were analyzed by direct sequencing in all family members. It demonstrated that in each of three patients, a previously reported nonsense mutation p.R333() was in cis with a novel missense mutation p.M49L in the minor allele characterized by the polymorphism of 74-bp duplication in intron 1, while the other novel missense mutation p.N72I was in trans with both p.R333() and P.M49L in the major allele. Kidney stones from two sibling patients were also observed though stereomicroscopic examination and scanning electron microscopy. Distinct morphological and inner-structure differences in calculi were noticed, suggesting clinical heterozygosity of PH1 to a certain extent. In brief, two novel missense mutations were identified probably in association with PH1, a finding which should provide an accurate tool for prenatal diagnosis, genetic counseling and screening for potential presymptomatic individuals.
原发性高草酸尿症 1 型(PH1)是一种罕见的遗传性疾病,其特征是血浆和尿液中草酸盐过度积累,由于等位基因和临床异质性,导致出现各种表型。本研究旨在检测一个中国家庭的 3 名 PH1 患者相关的遗传突变。通过对所有家庭成员进行直接测序,分析了 AGXT 所有外显子和 3 个常见的多态性,这些多态性可能与突变协同作用,包括 P11L、I340M 和 IVSI+74bp。结果表明,在每个患者中,先前报道的无意义突变 p.R333()与新的错义突变 p.M49L 位于同一位点,后者的特征是 1 号内含子中的 74-bp 重复多态性。而另一个新的错义突变 p.N72I 则与 p.R333()和 p.M49L 位于不同的等位基因上。通过体视显微镜和扫描电子显微镜观察到两名同胞患者的肾结石。结石的形态和内部结构存在明显差异,表明 PH1 存在一定程度的临床杂合性。总之,鉴定出了两个可能与 PH1 相关的新的错义突变,这为产前诊断、遗传咨询和潜在的症状前个体筛查提供了准确的工具。